INDICAID™ HPV Urine Test (with Report)
INDICAID HPV Cervical Cancer Screening Urine Test
INDICAID HPV Cervical Cancer Screening Urine Test
INDICAID HPV Cervical Cancer Screening Urine Test
INDICAID HPV Cervical Cancer Screening Urine Test

INDICAID™ HPV Urine Test (with Report)

$1,280.00 HKD
  • World's first cervical cancer screening test with patented urine DNA concentration technology developed in HK
  • 98.5% urine test accuracy agreement with HPV cervical / penile swab tests with patented PHASiFY technology*
  • Detect 27 types of HPV at once, lowering the risk of developing over 95% of cervical cancer1
  • Non-invasive, painless, private, easy-to-use
  • Suitable for men & women, protecting yourself and your partner from infection
  • Sample pick-up ($120) / drop-off service
  • 電子化驗報告將於樣本送達化驗所後5個工作天內以手機短訊及電郵發出
  • Follow-up care can be arranged when HPV is detected
Share
INDICAID™ HPV Urine Test (with Report)

INDICAID™ HPV Urine Test (with Report)

$1,280.00 HKD

INDICAID HPV Urine Test is an accurate, private and easy-to-use cervical cancer screening test that detects the presence of HPV. Empowered by the patented PHASiFY technology for urine DNA concentration and Oxford Nanopore Technologies (ONT), the test can detect 27 types of HPV (14 high-risk HPVs and 13 low-risk HPVs) in urine samples⁺, providing you a more efficient, convenient and comprehensive analysis of your cervical cancer risk.

Remarks
*Comparison with HPV cervical / penile swab test results demonstrates that the accuracy of INDICAID HPV Urine test has an overall agreement of 98.5%

+INDICAID HPV Urine Test can detect 27 types of HPV, including:

  • 14 high-risk HPVs:16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68
  • 13 low-risk HPVs:6, 11, 26, 30, 34, 53, 67, 69, 70, 73, 82, 85, 97
Before You Purchase
  1. Users must be at least 18 years old.
  2. A Hong Kong or a Mainland Chinese mobile phone number is required verification and collection of the HPV test report.
  3. Women should avoid collecting specimens during menstruation, as the presence of excessive impurities may affect the accuracy of test results.
Orders & Delivery
  1. Enjoy free delivery service when you spend $600 or more per order; standard delivery fee is $40 for orders below $600
  2. Orders will be delivered within 2 working days (except for remote areas). You will be notified via SMS upon the arrival of your product. In special circumstances such as long holidays or bad weather, delivery may be postponed for an additional 1 to 2 working days
  3. Express Delivery available with an additional $250 delivery fee
  • Same day delivery for orders before 3pm from Monday to Friday
  • Delivery on the next working day for orders after 3pm from Monday to Friday
  • Delivery on the next working day for orders after Friday 3pm, during weekends and public holidays
  1. Sales and delivery only available in HK
Patented Technology for Urine DNA Concentration
牛津納米孔 DNA 定序技術

兩大技術加持 — 比傳統子宮頸癌篩查方法更早、更方便、更全面測出子宮頸癌風險

尿液檢測準確度媲美子宮頸/陰莖拭子檢測

採用 PHASiFY™ 技術處理大量尿液樣本,超濃縮及純化樣本中的游離基因
  • Enhance the sensitivity and accuracy of urine samples
  • Avoid embarrassment through self-collection of urine sample
  • Allow you to analyze your cervical cancer risk early
效果更勝傳統 HPV 測試採用的核酸技術

Combined with DNA sequencing technology ONT, which was selected as "Method of the Year 2022" by the renowned scientific journal "Nature Methods"2
  • Detect more HPV subtypes within a shorter period of time
  • Identify 27 HPV subtypes individually
Urine test as accurate as cervical / penile sample tests

採用 PHASiFY™ 技術處理大量尿液樣本,超濃縮及純化樣本中的游離基因
  • Enhance the sensitivity and accuracy of urine samples
  • Avoid embarrassment through self-collection of urine sample
  • Allow you to analyze your cervical cancer risk early
More advanced than traditional PCR-based HPV tests

Combined with DNA sequencing technology ONT, which was selected as "Method of the Year 2022" by the renowned scientific journal "Nature Methods"2
  • Detect more HPV subtypes within a shorter period of time
  • Identify 27 HPV subtypes individually
香港平均每日 >1 名女性患上子宮頸癌
在 2020 年,子宮頸癌是香港女性第 7 常見的癌症,全年共有 556 宗新症,每 10 萬名女性就有 13.7 人發病。根據 2021 年數據顯示,子宮頸癌於本港女性致命癌症中更排第 8 位3
>95%子宮頸癌由高風險HPV病毒引致
世衛指出大部份子宮頸癌病例均是由 HPV 引致,一般女性會於感染後 15-20 年發展成子宮頸癌;免疫系統較弱的女性則只需 5-10 年1
HPV 檢測是子宮頸癌篩查首推方法

WHO recommends that HPV test is the most cost-effective technique for cervical screening. Detection of HPV infections that leads to cellular transformation followed by timely treatment can lower the risk of developing over 95% of cervical cancer1

Starting from 2023, the Department of Health of Hong Kong also enhanced its cervical cancer screening services by replacing Pap smear tests with a higher sensitivity HPV test4.

多數 HPV 感染無病徵,潛伏期逾10年

HPV infection can be easily transmitted through any intimate skin-to-skin contact, incl. vaginal–penile sex, penile–anal sex, penile–oral sex, vaginal–oral sex, and use of sex toys or other objects5.

感染高風險 HPV 及其引致的癌前病變甚少會引發病徵,女性一般會於持續感染後 15-20 年才會發展成子宮頸癌。因此,進行恆常 HPV 檢測作為子宮頸癌篩查尢其重要。

一些低風險 HPV 病毒屬於可能致癌的 2A 及 2B 類致癌物6; while some may cause genital warts on the prepuce, glans of the penis, urethral opening, anus, vulva, labia, vagina or cervix7.

接種 HPV 疫苗亦需定期進行HPV 檢測

HPV vaccine is effective in preventing the targeted HPV types that most commonly cause cervical cancer and genital warts, but not all types of HPV that can cause cervical cancer8.

Also, HPV vaccine does not treat existing HPV infections, which is why regular HPV screening tests for cervical cancer are strongly recommended8.

Detect 27 types of HPV at once
14 high-risk HPVs
16 18 31 33 35 39 45 51 52 56 58 59 66 68

Persistent infection with high-risk HPVs can lead to cervical, vaginal, vulvar and penile cancers etc.5

13 low-risk HPVs
6 11 26 30 34 53 67 69 70 73 82 85 97

Over 90% of the genital warts are associated with HPV-6 and HPV-11 infection10, which usually appear on the prepuce, glans of the penis, urethral opening, anus, vulva, labia, vagina or cervix7; while other low-risk HPVs are classified as Group 2A and 2B carcinogens - probably and possibly carcinogenic to humans6

Some groups are at a higher risk of infection!11
Early first sexual intercourse Multiple sexual partners Active sex life Unsafe sex 吸煙人士 Chronic immunosuppression Use of contraceptive pills Pregnant / postpartum women

1. Urine Self-Test Kit


  • Urine collection bottle
  • Preservative
  • Sample bag
  • Outer bag
  • Sample label
  • Disposable gloves (1 pair)

2. Digital Lab Test Report


Digital lab test report issued via SMS and email 5 working days after the lab receives the sample - detecting and indicating 27 HPV subtypes at once.

3. Follow-up care arrangement when HPV is detected


如檢測HPV 病毒陽性,我們會主動與您聯絡提供協助。

Accurate · Private · Easy-to-use

1

Activate your kit online

2

Collect your urine sample

3

Sample pick-up ($120) / drop-off service

How to return your sample?

Pick-up
專人上門收取樣本費用為$120。下午2時前完成填寫電子登記表,最快可預約下一個工作天由專人上門收件(週末及公眾假期除外),詳情請參考下方須知。
Drop-off
您可以於採樣後 24 小時內自行遞交樣本至樣本收集站。遞交樣本時需要開啟確認短訊上的連結,並掃描樣本收集箱上的二維碼以確認遞交日期和時間。
Before Your Sample Submission
遞交尿液樣本前請確保符合以下條件,否則樣本將不獲處理和退款:
  1. 掃瞄您的二維碼,填妥線上表格和選擇樣本遞交方式
  2. 已將保存液倒入已載有尿液的採樣瓶中
  3. 已填寫樣本標貼並張貼在採樣瓶上
  4. Had your sample picked up / dropped off on or before the expiry date listed on the test kit
More About Sample Pick-Up
專人上門收取樣本費用為$120。填寫線上表格時可選擇專人上門收取樣本,並選擇收取日期和時間。下午2時前完成填寫電子登記表,最快可預約下一個工作天由專人上門收件(週末及公眾假期除外):
  • 星期五下午2時前完成登記,最快可安排於下星期一上門收件
  • 星期五下午2時後完成登記,最快可安排於下星期二上門收件

    Pick-up service is currently unavailable for remote areas. You can choose to drop off your sample to our drop-off points.

  • What's next

    Different follow-up actions should be made depending on the HPV results.
    Detected

    Please seek medical advice. More regular HPV screening tests are recommended for continuous monitoring.

    如檢測HPV 病毒陽性,我們會主動與您聯絡提供協助。

    Not Detected

    Routine HPV screening tests for cervical cancer should be done. If you experience any swelling, bleeding, pain or other discomfort, seek medical advice promptly.
    INDICAID HPV Cervical Cancer Screening Urine Test - earlier analysis of your cervical cancer risk than Pap smear test
    Highly Recommended by Users
    FAQs
    可否取代柏氏抺片檢查?

    INDICAID™妥析™ HPV 尿液樣本測試與柏氏抺片檢查屬於兩種不同的技術。

    INDICAID™妥析™ HPV 尿液樣本測試主要檢測用家的尿液樣本中是否存有 HPV 病毒;而柏氏抺片則是由化驗所人員透過顯微鏡,檢視子宮頸細胞樣本有否出現異常,判斷子宮頸是否存在癌前病變。

    If your HPV DNA test detects HPV from your sample, you may consider undergoing a Pap smear test to verify if there is any abnormalities with your cervical cells.

    是否只適用於女士?男士也可以使用嗎?為甚麼?

    It is suitable for both men and women. It is reported that 80% of men and women will acquire HPV in their lifetime, everyone can transmit HPV to their partners. Therefore, it is recommended to get tested for HPV regularly to protect yourself and your partner9

    部分市場上的 HPV 測試產品要求自行於陰道內採樣,因此只適合女士使用。INDICAID™妥析™ HPV 尿液樣本測試是透過尿液樣本來檢測用家是否存有 HPV DNA,因此沒有性別限制,男女同時適用。

    如何進行測試,操作複雜嗎?

    Activate your kit online

    1. 掃描您的專屬二維碼
    2. 填寫線上表格
    3. Choose your sample submission method
    Collect your urine sample
    1. 採集排尿的首段 90-100亳升尿液樣本於採樣瓶內
    2. 將保存液倒入已載有尿液的採樣瓶中
    3. Re-cap tightly the filled urine collection bottle. Gently invert 3-5 times to mix the urine with the preservative
    Pack & return your sample
    1. 填寫樣本標貼並張貼在已裝滿尿液的採樣瓶上
    2. 將採樣瓶放入樣本袋中並將其密封
    3. 將封好的樣本袋放入外包裝袋中並將其密封
    4. 必須於採樣後24小時內根據已選擇的樣本遞交方式遞交樣本
    如何收到報告?何時會收到報告?

    電子化驗報告將於樣本送達化驗所後5個工作天內以手機短訊及電郵發出

    可以發出正式蓋印的收據嗎?

    Please contact our customer service at 3700 8888 for a receipt.

    References

    1. Bruni L, Albero G, Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. CO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. Summary Report 10 March 2023.
    2. Marx, V. Method of the year: long-read sequencing. Nat Methods 20, 6–11 (2023).
    3. Centre for Health Protection: Health Topics on Cervical Cancer (2023).
    4. Department of Health: DH introduces human papillomavirus testing and calls on public to undergo regular cervical cancer screening (2023).
    5. Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol. 2020 Jul;40(5):602-608. doi: 10.1080/01443615.2019.1634030. Epub 2019 Sep 10. Erratum in: J Obstet Gynaecol. 2020 May;40(4):590. PMID: 31500479; PMCID: PMC7062568.
    6. International Agency for Research on Cancer: IARC Monographs on the Identification of Carcinogenic Hazards to Humans (2023).
    7. The Family Planning Association of Hong Kong: Health Info on Sexually Transmissible Diseases. Accessed on 30th June 2023.
    8. Human papillomavirus vaccines: WHO position paper, December 2022. WHO REFERENCE NUMBER: WER No 50, 2022, 97, 645–672
    9. Chesson, Harrell W. PhD; Dunne, Eileen F. MD, MPH; Hariri, Susan PhD; Markowitz, Lauri E. MD. The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States. Sexually Transmitted Diseases 41(11):p 660-664, November 2014.
    10. Scientific Committee on Vaccine Preventable Diseases and Scientific Committee on AIDS and STI, Centre for Health Protection: Consensus Statement on the use of Human Papillomavirus (HPV) Vaccine in prevention of cervical cancer (2016).
    11. Cancer Expert Working Group on Cancer Prevention and Screening (CEWG), Centre for Health Protection: Recommendations on Prevention and Screening for Cervical Cancer For Health Professionals (2021).